Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China

• Main Authors: Wen Zeng (Author), Ning Liu (Author), Yuchun Li (Author), Ai Gao (Author), Mengyi Yuan (Author), Rui Ma (Author), Na Jiang (Author), Dingwei Sun (Author), Guangze Wang (Author), Xinyu Feng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Primaquine, the only licensed antimalarial drug for eradication of Plasmodium vivax and Plasmodium ovale malaria, may cause acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd) during treatment. The different prevalence and distribution patterns of G6PDd in...